Form 8-K - Current report:
SEC Accession No. 0001193125-18-319030
Filing Date
2018-11-06
Accepted
2018-11-06 08:08:58
Documents
3
Period of Report
2018-11-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d627629d8k.htm 8-K 18259
2 EX-99.1 d627629dex991.htm EX-99.1 9151
3 GRAPHIC g627629snap0002.jpg GRAPHIC 4991
  Complete submission text file 0001193125-18-319030.txt   35657
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 181161565
SIC: 2834 Pharmaceutical Preparations